• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱癌诊断的时间延迟——社会心理参数和医疗保健水平的影响

Time lag to diagnosis of bladder cancer--influence of psychosocial parameters and level of health-care provision.

作者信息

Månsson A, Anderson H, Colleen S

机构信息

Department of Urology, University Hospital, Lund, Sweden.

出版信息

Scand J Urol Nephrol. 1993;27(3):363-9. doi: 10.3109/00365599309180448.

DOI:10.3109/00365599309180448
PMID:8290917
Abstract

Delay in diagnosis of carcinoma of the urinary bladder was studied in 343 patients. The median patient's delay (time from first symptom to first consultation) was 15 days, and was longer when the only presenting symptom was urgency of micturition than when it was haematuria (45 vs. 5 days, p < 0.001). In advanced (T2-T4) tumour, patient's delay was 21 days and in Ta-T1 it was 13 days (NS). The median doctor's delay (time from first consultation to diagnosis) was 62 days. It comprised two phases: A from consultation to first referral and B from first referral to diagnosis-respective medians 6 and 47 days. Median doctor's delay (A+B) was longer when the initial consultation was with a general practitioner than with a urologist (78 vs. 21 days, p < 0.001) and longer in patients older than 70 years (69 vs. 54 days, p < 0.01). Doctor's delay correlated with symptoms, being longest in cases with only urgency and shortest in haematuria plus pain (114 vs. 44 days, p < 0.001), and also with number of referrals (33, 63, 230 and 117 days, respectively, for 0, 1, 2 and 3 referrals). More women than men were referred a second or third time (25.6% vs. 8.6%, p < 0.001), and doctor's delay was longer for women (76 vs. 59 days, p < 0.05). A questionnaire completed by 203 of the 229 surviving patients revealed no significant correlation between psychosocioeconomic factors and patient's delay.

摘要

对343例膀胱癌患者的诊断延迟情况进行了研究。患者的中位延迟时间(从出现首个症状到首次就诊的时间)为15天,当唯一的首发症状为尿频时,患者的延迟时间比出现血尿时更长(45天对5天,p<0.001)。在晚期(T2 - T4)肿瘤患者中,患者的延迟时间为21天,Ta - T1期患者为13天(无显著差异)。医生的中位延迟时间(从首次就诊到确诊的时间)为62天。这包括两个阶段:A阶段从就诊到首次转诊,B阶段从首次转诊到确诊,各自的中位时间分别为6天和47天。当首次就诊是看全科医生时,医生的中位延迟时间(A + B)比看泌尿科医生时更长(78天对21天,p<0.001),70岁以上患者的医生延迟时间也更长(69天对54天,p<0.01)。医生的延迟与症状有关,仅表现为尿频的病例延迟时间最长,血尿伴疼痛的病例延迟时间最短(114天对44天,p<0.001),并且也与转诊次数有关(0次、1次、2次和3次转诊的患者分别为33天、63天、230天和117天)。女性比男性被二次或三次转诊的比例更高(25.6%对8.6%,p<0.001),女性的医生延迟时间也更长(76天对59天,p<0.05)。229例存活患者中有203例完成的一份问卷显示,社会心理经济因素与患者延迟之间无显著相关性。

相似文献

1
Time lag to diagnosis of bladder cancer--influence of psychosocial parameters and level of health-care provision.膀胱癌诊断的时间延迟——社会心理参数和医疗保健水平的影响
Scand J Urol Nephrol. 1993;27(3):363-9. doi: 10.3109/00365599309180448.
2
Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?临床症状和转诊模式的差异是否导致膀胱癌的性别差距?
BJU Int. 2013 Jul;112(1):68-73. doi: 10.1111/j.1464-410X.2012.11661.x. Epub 2013 Jan 15.
3
[A study of case findings in pulmonary tuberculosis patients].[肺结核患者病例发现情况的研究]
Kekkaku. 2002 Sep;77(9):621-5.
4
Predictors of delay to cystoscopy and adequacy of investigations in patients with haematuria.血尿患者膀胱镜检查延迟及检查充分性的预测因素
BJU Int. 2017 May;119 Suppl 5:19-25. doi: 10.1111/bju.13809.
5
Diagnostic pathway efficacy for urinary tract cancer: population-based outcome of standardized evaluation for macroscopic haematuria.尿路癌的诊断途径疗效:基于人群的肉眼血尿标准化评估结果
Scand J Urol. 2018 Aug;52(4):237-243. doi: 10.1080/21681805.2018.1498124. Epub 2018 Nov 9.
6
[A study of patient's and doctor's delay in patients with pulmonary tuberculosis discovered by visiting doctors with symptoms in particular on doctor's delay].一项关于通过对有症状患者进行访视而发现的肺结核患者的患者延误和医生延误的研究,尤其关注医生延误。
Kekkaku. 2000 Sep;75(9):527-32.
7
Delay and survival in bladder cancer.膀胱癌的延迟与生存
BJU Int. 2002 Jun;89(9):868-78. doi: 10.1046/j.1464-410x.2002.02776.x.
8
Barriers in accessing to tuberculosis care among non-residents in Shanghai: a descriptive study of delays in diagnosis.上海非户籍居民获得结核病治疗的障碍:一项关于诊断延误的描述性研究
Eur J Public Health. 2007 Oct;17(5):419-23. doi: 10.1093/eurpub/ckm029. Epub 2007 Apr 4.
9
Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.临床表现和等待时间目标并不影响胰腺癌患者的预后。
Surgeon. 2010 Oct;8(5):239-46. doi: 10.1016/j.surge.2010.03.001. Epub 2010 Apr 2.
10
Doctors' characteristics and practice patterns in general practice: an analysis based on management of urinary incontinence.
Scand J Prim Health Care. 1990 Sep;8(3):179-82. doi: 10.3109/02813439008994953.

引用本文的文献

1
The Effect of Sex on Disease Stage and Survival after Radical Cystectomy in Non-Urothelial Variant-Histology Bladder Cancer.性别对非尿路上皮变异组织学类型膀胱癌根治性膀胱切除术后疾病分期及生存的影响。
J Clin Med. 2023 Feb 23;12(5):1776. doi: 10.3390/jcm12051776.
2
Perioperative, oncological, and survival outcomes of robotic radical cystectomy with urinary diversion in females: A single-center retrospective observational study.女性机器人根治性膀胱切除术伴尿流改道的围手术期、肿瘤学及生存结局:一项单中心回顾性观察研究
Indian J Urol. 2023 Jan-Mar;39(1):27-32. doi: 10.4103/iju.iju_179_21. Epub 2022 Dec 29.
3
Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges-a narrative review.
女性根治性膀胱切除术与尿流改道:技术、结果及挑战——一项叙述性综述
Transl Androl Urol. 2022 Nov;11(11):1598-1610. doi: 10.21037/tau-22-463.
4
Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer.非尿路上皮变异组织学类型的非肌层浸润性膀胱癌中的性别差异。
Cent European J Urol. 2022;75(3):240-247. doi: 10.5173/ceju.2022.0053. Epub 2022 Jul 18.
5
Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis.性别对非肌肉浸润性和肌肉浸润性膀胱尿路上皮癌手术后结局的影响:系统评价和荟萃分析。
World J Urol. 2023 Apr;41(4):909-919. doi: 10.1007/s00345-022-04116-x. Epub 2022 Aug 13.
6
Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study.波兰原发性膀胱癌患者的诊断和治疗延误:一项调查研究。
Cent European J Urol. 2020;73(2):152-159. doi: 10.5173/ceju.2020.0158. Epub 2020 Jun 18.
7
Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial.膀胱癌高复发风险患者的症状和诊断延迟:来自前瞻性 FinnBladder 9 试验的结果。
World J Urol. 2020 Apr;38(4):1001-1007. doi: 10.1007/s00345-019-02841-4. Epub 2019 Jun 8.
8
Review on gender differences in non-muscle invasive bladder cancer.非肌层浸润性膀胱癌的性别差异综述
Transl Androl Urol. 2019 Feb;8(1):12-20. doi: 10.21037/tau.2018.11.06.
9
Oncologic, Perioperative Outcomes of Female Radical Cystectomy: Results from a Multicenter Study in Korea.韩国多中心研究:女性根治性膀胱切除术的肿瘤学、围手术期结果。
Cancer Res Treat. 2019 Jul;51(3):1064-1072. doi: 10.4143/crt.2018.515. Epub 2018 Oct 30.
10
Geographic Variation in Cystoscopy Rates for Suspected Bladder Cancer between Female and Male Medicare Beneficiaries.女性和男性医疗保险受益人间疑似膀胱癌膀胱镜检查率的地理差异
Urology. 2018 Dec;122:83-88. doi: 10.1016/j.urology.2018.08.011. Epub 2018 Aug 20.